50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today COLL ranks #11406 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$17.95 (-3.13%)

Volume: 220k

Closed: Nov 26, 2021

Hollow Logo Score: -3.926

Collegium Pharmaceutical Stock Forecast

$17.95 (-3.13%)

Volume: 220k

Closed: Nov 26, 2021

Score Hollow Logo -3.926
Which way will COLL go? Request
Key Stats
P/E Ratio 5.99
Beta 0.55
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 38 and the stock is currently not being overbought or oversold

Red day on Friday for Collegium Pharmaceutical
(Updated on Nov 26, 2021)


Sell candidate since 2021-11-15 Loss -10.29%

The Collegium Pharmaceutical stock price fell by -3.13% on the last day (Friday, 26th Nov 2021) from $18.53 to $17.95. and has now fallen 3 days in a row. During the day the stock fluctuated 4.18% from a day low at $17.57 to a day high of $18.31. The price has fallen in 8 of the last 10 days and is down by -10.79% for this period. Volume has increased on the last day by 19 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 220 thousand shares were bought and sold for approximately $3.94 million.

The stock has broken the falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($18.90) are considered to be a "second chance" to get out. According to the fan-theory $17.61 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Signals & Forecast

There are few to no technical positive signals at the moment. The Collegium Pharmaceutical stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $18.76 and $20.10. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 08, 2021, and so far it has fallen -11.75%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.73 between high and low, or 4.18%. For the last week, the stock has had a daily average volatility of 3.05%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Collegium Pharmaceutical stock A Buy?

Collegium Pharmaceutical holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.926

Predicted Opening Price for Collegium Pharmaceutical of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$17.94 $17.95 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 15, 2021 "Needham & Company LLC" gave "$26.00 - $28.00" rating for COLL. The price target was set to $19.99+2.6%.

Volatility and Risk
Daily Average Volatility: 3.05 %
Overall Risk: Very High High Medium Low Very Low
Volatility
3.05 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $19.63
Price: $17.95
No Support Found

COLL Insider Trading Show all Trades

INSIDER POWER

3.249

Last 100 transactions
Buy: 1 757 767 | Sell: 540 989 (Shares)
Date Action Amount Person Type
Aug 10, 2021 Sell 1 386 Fleming Alison B Common Stock
Aug 10, 2021 Sell 1 386 Ciaffoni Joseph Common Stock
Jul 12, 2021 Sell 595 Dreyer Scott Common Stock
Jul 01, 2021 Sell 1 394 Ciaffoni Joseph Common Stock
Jun 02, 2021 Sell 5 861 Ciaffoni Joseph Common Stock
Show all Insider Trades
INSIDER POWER

3.249

Last 100 transactions
Buy: 1 757 767 | Sell: 540 989 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 18.68 4.05 %
18.40 2.48 %
18.22 1.52 %
Current price: 17.95
Support 17.66 -1.61 %
17.49 -2.58 %
17.21 -4.14 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 19.86 10.64 %
19.83 10.47 %
19.63 9.36 %
Current price 17.95
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an oral formulation of oxycodone. The company is also developing COL-195, a hydrocodone for the treatment of chronic pain; COL-172, an oxymorphone for the treatment of chronic pain; COL-19... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT